Newtyn Management’s Chimerix, Inc. CMRX Stock Holding History

Newtyn Management’s Portfolio CMRX Stock Details CMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,516,000	Closed	-$1.91M	–	78
2023 Q1	$1.91M	Buy	+1,516,000	New	+$2.47M	0.38%	47

Other funds holding CMRX

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Newtyn Management's CMRX Position: Q2 2023 in Review

Newtyn Management sold out of Chimerix, Inc. (CMRX) in Q2 2023, closing a stake of 1,516,000 shares — an estimated $1.91M sold.

Newtyn Management first reported a position in CMRX in Q1 2023 and held it in 1 quarter. The position peaked at $1.91M in Q1 2023. 96 funds tracked by Wall St. Rank hold CMRX as of Q2 2023.

Newtyn Management reported no remaining Chimerix, Inc. position as of Q2 2023 after selling out during the quarter.
Newtyn Management sold 1,516,000 Chimerix, Inc. shares in Q2 2023, an estimated $1.91M.
Newtyn Management first reported a position in Chimerix, Inc. in Q1 2023 and held it in 1 quarter.
Newtyn Management's Chimerix, Inc. position peaked at $1.91M in Q1 2023.
96 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q2 2023.

Based on Newtyn Management's 13F filing for Q2 2023, filed 14 Aug 2023.